Your browser doesn't support javascript.
loading
PSMA PET/CT: joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0.
Fendler, Wolfgang P; Eiber, Matthias; Beheshti, Mohsen; Bomanji, Jamshed; Calais, Jeremie; Ceci, Francesco; Cho, Steve Y; Fanti, Stefano; Giesel, Frederik L; Goffin, Karolien; Haberkorn, Uwe; Jacene, Heather; Koo, Phillip J; Kopka, Klaus; Krause, Bernd J; Lindenberg, Liza; Marcus, Charles; Mottaghy, Felix M; Oprea-Lager, Daniela E; Osborne, Joseph R; Piert, Morand; Rowe, Steven P; Schöder, Heiko; Wan, Simon; Wester, Hans-Jürgen; Hope, Thomas A; Herrmann, Ken.
Affiliation
  • Fendler WP; Department of Nuclear Medicine, University of Duisburg-Essen and German Cancer Consortium (DKTK)-University Hospital Essen, Hufelandstraße 55, 45147, Essen, Germany.
  • Eiber M; PET Committee of the German Society of Nuclear Medicine, Marburg, Germany.
  • Beheshti M; Department of Nuclear Medicine, Klinikum Rechts Der Isar, Technical University of Munich, Munich, Germany.
  • Bomanji J; Division of Molecular Imaging & Theranostics, Department of Nuclear Medicine, University Hospital Salzburg, Paracelsus Medical University, Salzburg, Austria.
  • Calais J; Institute of Nuclear Medicine, UCLH NHS Foundation Trust, London, UK.
  • Ceci F; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, University of California Los Angeles, Los Angeles, CA, USA.
  • Cho SY; Division of Nuclear Medicine and Theranostics, IEO European Institute of Oncology, IRCCS, Milan, Italy.
  • Fanti S; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
  • Giesel FL; Department of Radiology, School of Medicine and Public Health, University of Wisconsin, Madison, WI, USA.
  • Goffin K; IRCCS, AOU Bologna, Bologna, Italy.
  • Haberkorn U; Department of Nuclear Medicine, University Hospital Düsseldorf, Medical Faculty, Heinrich-Heine-University and Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany.
  • Jacene H; Department of Nuclear Medicine, Division of Nuclear Medicine and Molecular Imaging, University Hospital Leuven, KU Leuven, Louvain, Belgium.
  • Koo PJ; Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany.
  • Kopka K; Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston, USA.
  • Krause BJ; Banner MD Anderson Cancer Center, Phoenix, AZ, USA.
  • Lindenberg L; Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.
  • Marcus C; School of Science, Faculty of Chemistry and Food Chemistry, Technical University Dresden, Dresden, Germany.
  • Mottaghy FM; German Cancer Consortium (DKTK), Partner Site Dresden, Dresden, Germany.
  • Oprea-Lager DE; Department of Nuclear Medicine, University Medical Center, University of Rostock, Rostock, Germany.
  • Osborne JR; Molecular Imaging Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, USA.
  • Piert M; Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Emory University School of Medicine, Atlanta, GA, USA.
  • Rowe SP; Department of Nuclear Medicine, University Hospital RWTH Aachen University, Aachen, Germany.
  • Schöder H; Department of Radiology and Nuclear Medicine, Maastricht University Medical Center (MUMC+), Maastricht, The Netherlands.
  • Wan S; Department of Radiology & Nuclear Medicine, Amsterdam University Medical Centers, VU University Medical Center, Cancer Center Amsterdam, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.
  • Wester HJ; Department of Radiology, Division of Molecular Imaging and Therapeutics, Weill Cornell Medicine, New York, NY, USA.
  • Hope TA; Department of Radiology, Division of Nuclear Medicine and Molecular Imaging, University of Michigan, Ann Arbor, MI, USA.
  • Herrmann K; Division of Nuclear Medicine and Molecular Imaging, The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Eur J Nucl Med Mol Imaging ; 50(5): 1466-1486, 2023 04.
Article in En | MEDLINE | ID: mdl-36604326
ABSTRACT
Here we aim to provide updated guidance and standards for the indication, acquisition, and interpretation of PSMA PET/CT for prostate cancer imaging. Procedures and characteristics are reported for a variety of available PSMA small radioligands. Different scenarios for the clinical use of PSMA-ligand PET/CT are discussed. This document provides clinicians and technicians with the best available evidence, to support the implementation of PSMA PET/CT imaging in research and routine practice.
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Positron Emission Tomography Computed Tomography Type of study: Guideline Limits: Humans / Male Language: En Journal: Eur J Nucl Med Mol Imaging Journal subject: MEDICINA NUCLEAR Year: 2023 Type: Article Affiliation country: Germany
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Positron Emission Tomography Computed Tomography Type of study: Guideline Limits: Humans / Male Language: En Journal: Eur J Nucl Med Mol Imaging Journal subject: MEDICINA NUCLEAR Year: 2023 Type: Article Affiliation country: Germany